Eli Lilly (LLY) PT Raised to $1,327 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,273.46 -2.54%
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Join SI Premium – FREE
Morgan Stanley analyst Terence Flynn raised the price target on Eli Lilly (NYSE: LLY) to $1,327.00 (from $1,313.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Eli Lilly & Co. (LLY) call put ratio 1 call to 1 put into quarter results
- Lockheed Martin (LMT) PT Raised to $692 at UBS
- Deckers Outdoor (DECK) PT Lowered to $100 at Williams Trading
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
